Chairman of the Tokyo Medical Association: Household Doctors Should Prescribe Ivermectin to Treat COVID-19

UK’s MHRA ‘Aware’ of Global Ivermectin Study & Plans on Reviewing the Evidence

On February 9th a prominent member of the medical establishment here came out in a very public manner in favor of ivermectin as a treatment for not only patients infected with SARS-CoV-2, the virus behind COVID-19, but also their caregivers. Reported in The Nikkei, a prominent Japanese economics and business focused publication, Haruo Ozaki, chairman of the Tokyo Medical Association, came out and recommended the emergency use of drugs such as Ivermectin administered to those COVID-19 patients, declaring they exhibit efficacy toward preventing disease progression in other nations. Clearly, Dr. Ozaki falls on the side of a rapidly growing group of physicians and researchers that align with significant meta-analyses involving dozens of randomized controlled trials, observational studies and case series around the world. Ozaki also calls out for Japan health authorities to use dexamethasone shown to help lower the death rate in certain more severe situations in hospitalized patients.

What's Going On?

Although Marvin Gaye was taken away many years ago, the lyrics of perhaps his most remembered tune resonate in any generation confronting societal challenges, entrenched interests, ...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee